| Model Number |
FX596T |
| Medical Device Problem Code |
Infusion or Flow Problem (2964)
|
| Health Effect - Clinical Code |
Hydrocephalus (3272)
|
| Date of Event |
10/25/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that a progav 2.0 shuntsystem (part # fx596t) was implanted during a procedure performed on (b)(6) 2020.According to the complainant, the shunt system was believed to be operated in under- drainage.The patient underwent a revision procedure on (b)(6) 2022.The complaint device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 14 years, 11 months.Height: 168 centimeters (cm).Weight: 50 kilograms (kg).Gender: male.
|
| |
|
Additional Manufacturer Narrative
|
|
Cutting in the silicon membrane of the reservoir and deposits inside the reservoir were observed through the visual inspection.No significant deformations or damage were detected.A permeability test has shown that all components are permeable.To investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical positions.The results show that the valves operated within the accepted tolerance in both positions.The progav 2.0 was tested and is adjustable to all specified pressures.The brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.After dismantling of the valves, deposits were found in both valves.Based on our investigation results, we can determine deposits.The deposits had no effect to the technical properties at the time of the investigation.The cause of the aforementioned functional impairment is not known to us at the time of the examination.Proteins in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|
| |
|
Search Alerts/Recalls
|